![Ryan Witt](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ryan Witt
Corporate Officer/Principal bei RENOVORX, INC.
Ursprung des Netzwerks ersten Grades von Ryan Witt
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 8 | |
Public Company | Pharmaceuticals: Major | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Ryan Witt
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
CAPSTONE HOLDING CORP. | Pharmaceuticals: Major | Director/Board Member | |
GERON CORPORATION | Biotechnology | Director/Board Member | |
ALBANY MOLECULAR RESEARCH, INC. | Biotechnology | Director/Board Member | |
PTC THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
HeartFlow, Inc.
![]() HeartFlow, Inc. Packaged SoftwareTechnology Services HeartFlow, Inc. operates as a cardiovascular company which engages in diagnosing coronary artery diseases. The firm provides a patient-specific analysis of coronary blood flow utilizing coronary CT scans and proprietary computer algorithms based on computational fluid dynamics. The company was founded by Charles A. Taylor, Nathan M. Wilson, and Christopher K. Zarins in 2007 and is headquartered in Redwood City, CA. | Packaged Software | Corporate Officer/Principal | |
ForSight VISION4, Inc.
![]() ForSight VISION4, Inc. Pharmaceuticals: MajorHealth Technology ForSight VISION4, Inc. develops novel drug delivery therapies for treatment of retinal diseases. The company was founded on June 26, 009 and is headquartered in Menlo Park, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
ForSight VISION5, Inc.
![]() ForSight VISION5, Inc. Electronic Equipment/InstrumentsElectronic Technology ForSight VISION5, Inc. develops ocular drug delivery technologies and device solutions for ophthalmic diseases. It engages in the development of non-invasive products to replace eye drops and provide sustained therapy for major anterior segment eye diseases including glaucoma, dry eye, and allergy. Its lead product candidate is the Helios insert, a novel, non-invasive delivery system designed to allow glaucoma and ocular hypertensive patients to continually receive their medication. The company was founded by Eugene de Juan Jr., J. Andrew Corley and K. Angela Macfarlane in 2010 and is headquartered in Madison, NJ. | Electronic Equipment/Instruments | Founder | |
NEXIMMUNE, INC. | Pharmaceuticals: Major | Chairman | |
ForSight VISION6, Inc.
![]() ForSight VISION6, Inc. Medical/Nursing ServicesHealth Services ForSight VISION6, Inc. provides health care services. The company is headquartered in Brisbane, CA. | Medical/Nursing Services | Director/Board Member | |
University of Pennsylvania | College/University | Doctorate Degree | |
EVOTEC SE | Pharmaceuticals: Major | Corporate Officer/Principal | |
The American Institute of Certified Public Accountants
![]() The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of Utah | College/University | Corporate Officer/Principal | |
Talon Therapeutics, Inc.
![]() Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
University of Central Missouri | College/University | Graduate Degree | |
Duquesne University of The Holy Spirit | College/University | Undergraduate Degree | |
Golden Gate University | College/University | Graduate Degree | |
Yale University | College/University | Undergraduate Degree | |
University of California, Santa Barbara | College/University | Undergraduate Degree | |
University of Mary Hardin-Baylor | College/University | Graduate Degree | |
SUCAMPO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
WEIFA ASA | Pharmaceuticals: Major | Director/Board Member | |
CYCLACEL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
The Cancer Institute of New Jersey
![]() The Cancer Institute of New Jersey Hospital/Nursing ManagementHealth Services The Cancer Institute of New Jersey operates as a cancer centre. The firm offers cancer care for adults and children, providing access to the medicines and treatment options. It also offers clinical, patient education resources and support services. The company was founded in and is headquartered in New Brunswick, NJ. | Hospital/Nursing Management | Director/Board Member | |
El Camino Hospital
![]() El Camino Hospital Hospital/Nursing ManagementHealth Services El Camino Hospital owns and operates hospitals. It provides clinical and community health services such as cancer care, clinical trials, digestive health, emergency care, lung care, urology care, and diagnostic services. The company was founded in 1958 and is headquartered in Mountain View, CA. | Hospital/Nursing Management | Chief Tech/Sci/R&D Officer | |
Schering-Plough Research Institute
![]() Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
The Association of Bioscience Financial Officers
![]() The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services The Association of Bioscience Financial Officers operates as a national networking group for biotechnology, med tech and bioscience financial officers. The company was founded in 1988 and is headquartered in Menlo Park, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Weill Cornell Medical College | College/University | Corporate Officer/Principal | |
The University of Texas Southwestern Medical Center | College/University | Doctorate Degree | |
Worldwide Clinical Research, Inc.
![]() Worldwide Clinical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Part of dMed Biopharmaceutical Technology (Shanghai) Co., Ltd., Worldwide Clinical Research, Inc. provides management consulting services to the clinical research industry. The company is based in Overland Park, KS. The company was founded by Barbara J. Geiger. Worldwide Clinical Research was acquired by Clinipace, Inc., part of dMed Biopharmaceutical Technology (Shanghai) Co., Ltd. from April 28, 2021 on November 09, 2009. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
CancerCare of New Jersey | Director/Board Member | ||
Fogarty Institute For Innovation
![]() Fogarty Institute For Innovation Miscellaneous Commercial ServicesCommercial Services Fogarty Institute for Innovation is a non-profit company that believes innovation is the key to medical advancement. The company is based in Mountain View, CA. The company strives to shape the future of human health through their work. The company was founded by Thomas J. Fogarty. Andrew Cleeland has been the CEO of the company since 2017. | Miscellaneous Commercial Services | Director/Board Member | |
Chartered Global Management Accountant | Corporate Officer/Principal | ||
Vidac Pharma Ltd.
![]() Vidac Pharma Ltd. Pharmaceuticals: MajorHealth Technology Vidac Pharma Ltd. manufactures pharmaceutical products. It is a clinical stage biopharmaceutical company dedicated to discovering and developing first-in-class medicines to help people suffering from a range of oncologic and dermatologic diseases. The company was founded in 2011 by Max Herzberg is headquartered in Jerusalem, Israel. | Pharmaceuticals: Major | Director/Board Member | |
Spiegel Consultants, LLC | Founder | ||
Spiral Therapeutics, Inc.
![]() Spiral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Spiral Therapeutics, Inc. manufactures pharmaceutical products. The firm also develops therapies for inner ear disorders. The company was founded by Hugo Peris, Justin S. Hanes and Eugene de Juan in 2016 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member | |
PDS BIOTECHNOLOGY CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
Vensana Capital Management LLC
![]() Vensana Capital Management LLC Investment ManagersFinance Vensana Capital Management LLC (Vensana Capital) is a venture capital and growth equity investment firm founded in 2019 by Peter Klein Justin & Kirk G. Nielsen. The firm is headquartered in Saint Paul, Minnesota. | Investment Managers | Consultant / Advisor | |
Voyant Biotherapeutics LLC
![]() Voyant Biotherapeutics LLC BiotechnologyHealth Technology Voyant Biotherapeutics LLC develops ocular therapeutics to solve age-related macular degeneration. The private company is based in Menlo Park, CA. | Biotechnology | Chief Executive Officer | |
Recognify Life Sciences, Inc.
![]() Recognify Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Recognify Life Sciences, Inc. develops treatments for cognitive impairment associated with schizophrenia. The company is based in Brisbane, CA. The company was founded by Thomas C. Südhof, Matthew P. Pando, Kristen Angela MacFarlane, Gary Walker. Matthew P. Pando has been the CEO since incorporation. | Miscellaneous Commercial Services | Founder | |
SENSEI BIOTHERAPEUTICS, INC. | Biotechnology | Comptroller/Controller/Auditor | |
Perceive Biotherapeutics, Inc.
![]() Perceive Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Perceive Biotherapeutics, Inc. is a biotech company that is focused on developing a diverse pipeline of targets and treatment modalities for various therapeutic verticals, with a particular emphasis on ophthalmology. The company is based in South San Francisco, CA. Perceive is backed by Deerfield Management and is planning to raise a series B later this year. The company was founded based on research that identified two novel protective biologies for treating retinal blindness, which were developed from collaborations in genetic science and target validation. Kristen Angela MacFarlane has been the CEO of the company since 2020. | Pharmaceuticals: Major | Chief Executive Officer | |
ZOSANO PHARMA CORPORATION | Pharmaceuticals: Major | Chief Operating Officer | |
Ally CMC | Founder |
Statistik
International
Vereinigte Staaten | 47 |
Deutschland | 2 |
Norwegen | 2 |
Vereinigtes Königreich | 2 |
Israel | 2 |
Sektoral
Health Technology | 23 |
Consumer Services | 11 |
Commercial Services | 7 |
Health Services | 4 |
Technology Services | 3 |
Operativ
Director/Board Member | 61 |
Corporate Officer/Principal | 33 |
Independent Dir/Board Member | 18 |
Consultant / Advisor | 12 |
Chief Executive Officer | 11 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Una Ryan | 39 |
Laurence Marton | 30 |
Robert Spiegel | 30 |
Kristen MacFarlane | 18 |
Nandan Oza | 11 |
Ronald Kocak | 6 |
Leesa Gentry | 5 |
Ramtin Agah | 4 |
Shaun Bagai | 3 |